Organization
Weill Medical College of Cornell University
107 clinical trials
Clinical trial
A Window-of-opportunity Trial of Abemaciclib Followed by Radical Cystectomy in Patients With Platinum-ineligible Urothelial Carcinoma to Evaluate CDK4/6-dependent Phosphorylation of Pocket Proteins and Clonal Evolution DynamicsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)Status: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Randomized Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With High-Risk Castrate Biochemically Relapsed Prostate Cancer After Local TherapyStatus: Active (not recruiting), Estimated PCD: 2022-02-10
Clinical trial
Randomized Trial Comparing Transperineal vs. Transrectal MRI-targeted Prostate Biopsy; Randomized Controlled Trial Assessing Transperineal Prostate Biopsy to Reduce Infection ComplicationsStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell LymphomasStatus: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
The Efficacy, Safety, and Tolerability of Switching to a Bictegravir (BIC)/Emtricitabine(FTC)/Tenofovir Alafenamide (TAF) Regimen in Virally Suppressed HIV-Positive Patients Post-Renal TransplantStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
An Open-Label, Single-Center, Investigator Initiated Phase 1B Trial of E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal FistulasStatus: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
Pilot Pragmatic Clinical Trial of Oral Iron Therapy in Children With Chronic Kidney DiseaseStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 StudyStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
CIMER: Combined Immunotherapies in Metastatic ER+ Breast CancerStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)Status: Active (not recruiting), Estimated PCD: 2025-04-01
Clinical trial
A Prospective, Randomized, Placebo-controlled Trial of Fluconazole in Combination With IL-23 Therapy Versus IL-23 Therapy Alone for the Treatment of Crohn's DiseaseStatus: Not yet recruiting, Estimated PCD: 2028-12-01
Clinical trial
A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular LymphomaStatus: Recruiting, Estimated PCD: 2033-10-01
Clinical trial
Pilot Study of PSMA-TRT Re-treatment Utilizing 225Ac-J591Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's AtaxiaStatus: Recruiting, Estimated PCD: 2028-12-31
Clinical trial
Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk LeukemiaStatus: Terminated, Estimated PCD: 2022-06-24
Clinical trial
Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular ContractionsStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver MetastasesStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
HCV Test and Treat Utilizing Simplified HCV Patient EducationStatus: Recruiting, Estimated PCD: 2027-10-01
Clinical trial
A Phase 2 Trial of Paxalisib Combined With a Ketogenic Diet and Metformin for Newly Diagnosed and Recurrent GlioblastomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Converting HR+ Breast Cancer Into an Individualized VaccineStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Phase II Trial of CPX (Cytarabine:Daunorubicin) Liposome Injection in Patients >/=60 Years of Age With AML Previously Untreated By Intensive ChemotherapyStatus: Completed, Estimated PCD: 2018-12-19
Clinical trial
Open Label Phase II Trial of Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) and Known Amplifications or Activating Mutations in Gene Targets of Cabozantinib Who Have Received Prior Anti-Androgen TherapyStatus: Recruiting, Estimated PCD: 2024-05-31
Clinical trial
Phenylbutyrate for Monogenetic Developmental and Epileptic EncephalopathyStatus: , Estimated PCD: 2025-01-01
Clinical trial
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney DiseaseStatus: Completed, Estimated PCD: 2023-08-01
Clinical trial
Evaluation of Transperineal Biopsy Under Local Anesthesia, a Novel Approach to Decrease Post-Biopsy Infections and Improve Cancer DetectionStatus: Completed, Estimated PCD: 2024-04-19
Clinical trial
Phase I/II Dose-escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate CancerStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Phase I Dose-Escalation Trial of 225Ac-J591 in Patients With Metastatic Castration-Resistant Prostate CancerStatus: Completed, Estimated PCD: 2021-01-07
Clinical trial
Phase I/ll Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive Metastatic Castration Resistant Prostate CancerStatus: Active (not recruiting), Estimated PCD: 2021-09-30
Clinical trial
A Randomized Controlled Trial Comparing Low Doses Of Aspirin In The Prevention Of Preeclampsia (ASAPP)Status: , Estimated PCD: 2024-08-01
Clinical trial
Randomized, Multicenter Phase II Study of Pembrolizumab in Combination With Chemotherapy and Chemoradiation in Locally Advanced Esophageal AdenocarcinomaStatus: Active (not recruiting), Estimated PCD: 2021-02-10
Clinical trial
N-of-1 Trials for Deprescribing Beta-blockers in HFpEFStatus: Completed, Estimated PCD: 2023-04-28
Clinical trial
Assessing the Impact of Escitalopram on Sperm DNA Fragmentation: A Randomized Placebo ControlledStatus: Recruiting, Estimated PCD: 2028-12-01
Clinical trial
N-of-1 Trials to Promote Deprescribing in Older Adults With Transthyretin Cardiac AmyloidosisStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Phase I Randomized, Double-blind, Placebo Control Study for an Anti-cocaine VaccineStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
InterMediate ProphylACtic Versus Therapeutic Dose Anticoagulation in Critically Ill Patients With COVID-19: A Prospective Randomized Study (The IMPACT Trial)Status: Terminated, Estimated PCD: 2021-04-17
Clinical trial
Treatment of Early Hypertension Among Persons Living With HIV in HaitiStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Characterizing and Comparing the Duration of Local Anesthetic in Dermatologic SurgeryStatus: Completed, Estimated PCD: 2023-07-31
Clinical trial
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease and ControlsStatus: Active (not recruiting), Estimated PCD: 2024-04-30
Clinical trial
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) TrialStatus: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene CitrateStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Phase I, Open-Label, Dose-Finding Study of TVB-2640 Administered in Combination With Enzalutamide (Xtandi) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Status: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Feasibility of Onabotulinumtoxin A Injection on Improving Female Stress Urinary IncontinenceStatus: , Estimated PCD: 2024-08-01
Clinical trial
A Phase II Study of Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's MacroglobulinemiaStatus: Terminated, Estimated PCD: 2020-09-15
Clinical trial
Phase II Study of Lenalidomide Plus Rituximab in Patients With Previously Untreated Mantle Cell LymphomaStatus: Completed, Estimated PCD: 2014-04-01
Clinical trial
A Phase 2, Open-Label, Single-Arm Study of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaStatus: Terminated, Estimated PCD: 2022-11-30
Clinical trial
Naltrexone Treatment for Prolonged Grief Disorder: A Pilot StudyStatus: Terminated, Estimated PCD: 2023-10-16
Clinical trial
One Month Dual Antiplatelet Therapy With Ticagrelor in Coronary Artery Bypass Graft PatientsStatus: Not yet recruiting, Estimated PCD: 2027-01-01
Clinical trial
Pilot Clinical Trial of Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen (INTERCEPT Fibrinogen Complex) in Patients With Bleeding to Expedite Product Availability and Improve Outcomes in Perioperative BleedingStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Single Arm Study With Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination With Immunotherapy for Patients With Merkel Cell Cancer (HCRN MCC20-443; iPRRT Study)Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Phase I Trial of Tazemetostat in Combination With Venetoclax in Patients With Relapsed/Refractory Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
The Use of Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal SurgeryStatus: Completed, Estimated PCD: 2022-11-28
Clinical trial
A Randomized Phase 2 Trial of Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II, and IIIA Non-small Cell Lung Cancer (NSCLC)Status: Completed, Estimated PCD: 2020-09-16
Clinical trial
Phase II Study of Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's TransformationStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer'sStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Pilot Study of Rimegepant in Moderate Plaque-type PsoriasisStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Phase 1 Trial of Naptumomab Estafenatox (NAP) in Combination With Pembrolizumab (Pembro) Preceded by Obinutuzumab (Obi) in Patients With Urothelial CancersStatus: Withdrawn, Estimated PCD: 2025-12-01
Clinical trial
Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate CancerStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic ImagingStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase II Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Immunotherapy Refractory Esophagogastric AdenocarcinomaStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
N-of-1 Trials for Deprescribing Beta-blockers in HFpEFStatus: Completed, Estimated PCD: 2022-04-28
Clinical trial
Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric AdenocarcinomaStatus: Completed, Estimated PCD: 2023-06-20
Clinical trial
A Prospective Study of Optimal Cord Selection for Haplo-Cord Transplantation: Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA)Status: Active (not recruiting), Estimated PCD: 2023-08-09
Clinical trial
Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical TrialStatus: Terminated, Estimated PCD: 2023-09-17
Clinical trial
A Prospective Study of Tocilizumab for the Prevention of Graft Failure and Graft-versus-Host Disease in Haplo-Cord TransplantationStatus: Active (not recruiting), Estimated PCD: 2022-09-28
Clinical trial
Analysis of Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure AnalgesiaStatus: Completed, Estimated PCD: 2023-05-15
Clinical trial
A Randomized, Placebo-controlled Clinical Trial Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Subsequent Dietary Fiber in Patients With Moderate Ulcerative ColitisStatus: Completed, Estimated PCD: 2023-06-09
Clinical trial
Randomized Double-blind, Placebo-controlled Single Center Pilot Study to Evaluate the Efficacy and Safety of Baloxavir in Combination With Oseltamivir in Adult Allogeneic Bone Marrow Transplant Recipients With InfluenzaStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Phase II Study of High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor MalignanciesStatus: Completed, Estimated PCD: 2023-04-21
Clinical trial
Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate CancerStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Multi-center Phase II Study of CC486-CHOP in Patients With Previously Untreated Peripheral T-cell LymphomaStatus: Completed, Estimated PCD: 2020-03-25
Clinical trial
Phase II Study of Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel TherapyStatus: Terminated, Estimated PCD: 2022-01-21
Clinical trial
Intra-Arterial (IA) Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma (ACPP) and Choroid Plexus Carcinoma (CPC) Prior to Second-Look SurgeryStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcerStatus: Withdrawn, Estimated PCD: 2025-01-01
Clinical trial
Phase I/II Study of 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate CancerStatus: , Estimated PCD: 2024-12-24
Clinical trial
A Phase-I Trial for Simultaneous Imaging of Tumor Hypoxia and Proliferation in Patients With Treatment- Naïve High-Grade GliomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Effects of Perampanel on Neurophysiology Test PerimetersStatus: Completed, Estimated PCD: 2021-11-29
Clinical trial
Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail PsoriasisStatus: Completed, Estimated PCD: 2023-03-29
Clinical trial
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)Status: Terminated, Estimated PCD: 2022-03-11
Clinical trial
Zanubrutinib and Venetoclax as Initial Therapy for CLL With Obinutuzumab Consolidation in Patients With Minimal Residual Disease Positivity (BruVenG)Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
The Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail InjectionStatus: Withdrawn, Estimated PCD: 2025-02-01
Clinical trial
Phase II Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint InhibitorsStatus: Terminated, Estimated PCD: 2023-05-05
Clinical trial
Novel Exploratory Study to Test Combination of Botensilimab and Balstilimab Immunotherapy in Resectable Colorectal Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Phase I Trial, With an Expansion Cohort, of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Combination With Gemtuzumab in Subjects With Acute Myeloid Leukemia >55 Years of Age Who Have Not Been Treated With Intensive ChemotherapyStatus: Terminated, Estimated PCD: 2022-08-15
Clinical trial
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to DaratumumabStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Effect of Rimonabant, a Cannabinoid Receptor 1 Antagonist on Weight Gain and Body Composition in Adults With Prader Willi Syndrome.Status: Terminated, Estimated PCD: 2009-01-01
Clinical trial
A Preliminary Study for the Intervention of an N-of-1 Protocol For Medication OptimizationStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Phase II Study of Sequential Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Newly Diagnosed Multiple MyelomaStatus: Active (not recruiting), Estimated PCD: 2016-06-07
Clinical trial
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIVStatus: Active (not recruiting), Estimated PCD: 2026-04-01
Clinical trial
A Phase 2 Comparison Study of 68Ga-PSMA-HBED-CC Positron Emission Tomography (PET)/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate CancerStatus: Terminated, Estimated PCD: 2021-05-05
Clinical trial
Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell CountsStatus: Completed, Estimated PCD: 2019-11-14
Clinical trial
Phase II Trial of Platinum-Etoposide Chemotherapy and Durvalumab (MEDI4736) With Sub-Ablative SBRT in Patients With Newly Diagnosed Stage IV Small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
Comparison of Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles in the Management of Myofascial Pain Disorder: A Randomized Clinical TrialStatus: Completed, Estimated PCD: 2020-03-13
Clinical trial
Biomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
A Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)Status: Active (not recruiting), Estimated PCD: 2021-06-30
Clinical trial
Lenalidomide and Dexamethasone (Rd) Versus Clarithromycin [Biaxin®] / Lenalidomide [Revlimid®] / Dexamethasone (BiRd) as Initial Therapy in Multiple MyelomaStatus: Terminated, Estimated PCD: 2022-06-22
Clinical trial
A 2-tiered, Phase 2, Rule-based, Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib (TEW-7197) in the Treatment of Anemic Patients With Philadelphia Chromosome-negative MPNs (Ph-neg MPNs)Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Post COVID-19 Hypoxemic Respiratory Failure Residual Pathophysiologic OutcomesStatus: Completed, Estimated PCD: 2023-05-09
Clinical trial
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Pilot Study of Ceftolozane-Tazobactam in Conjunction With Rapid Molecular Diagnosis for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target EngagementStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
A Multiple-center Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab in Patients With Previous Untreated Mantle Cell LymphomaStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
SSTR2-Targeted PET Imaging of Meningioma: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOCStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Clinical trial
An Open-Label, Single-Center, Investigator Initiated Phase 1B Trial of E-CEL UVEC Cell Therapy for the Treatment of Chronic Anal FissureStatus: Not yet recruiting, Estimated PCD: 2025-06-30